Silencing PKD2 or PKD3 also significantly blocked HCC1806 triple-negative breast cancer cell proliferation, and in particular, PKD3 knockdown inhibited Hsp27 and HDAC4/5/7 phosphorylation [68]. Here, PRKD3 is linked to triple-negative breast carcinoma.